Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.
| Revenue (TTM) | $507.36M |
| Gross Profit (TTM) | $116.41M |
| EBITDA | $8.56M |
| Operating Margin | -16.00% |
| Return on Equity | -74.10% |
| Return on Assets | -4.02% |
| Revenue/Share (TTM) | $14.73 |
| Book Value | $2.21 |
| Price-to-Book | 0.12 |
| Price-to-Sales (TTM) | 0.02 |
| EV/Revenue | 0.95 |
| EV/EBITDA | 69.96 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -5.40% |
| Shares Outstanding | $34.89M |
| Float | $32.28M |
| % Insiders | 9.02% |
| % Institutions | 14.00% |
Volatility is currently contracting